Home
IMCR
IMCR News

Latest Immunocore Holdings plc (IMCR) News on October 26, 2025

Strength Seen in Kamada (KMDA): Can Its 9.5% Jump Turn into More Strength?

Zacks

4 months ago

Strength Seen in Kamada (KMDA): Can Its 9.5% Jump Turn into More Strength?

Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag

Zacks

4 months ago

Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag

FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer

Zacks

4 months ago

FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer

Wall Street Analysts Think Immunocore (IMCR) Could Surge 65.22%: Read This Before Placing a Bet

Zacks

5 months ago

Wall Street Analysts Think Immunocore (IMCR) Could Surge 65.22%: Read This Before Placing a Bet

Immunocore to present at the 2025 Jefferies Global Healthcare Conference

GlobeNewswire

5 months ago

Immunocore to present at the 2025 Jefferies Global Healthcare Conference

MT Newswires

5 months ago

Deutsche Bank Initiates Immunocore Holdings at Buy With $65 Price Target

Is it a Good Idea to Invest in Immunocore Stock Right Now?

Zacks

5 months ago

Is it a Good Idea to Invest in Immunocore Stock Right Now?

MT Newswires

6 months ago

Oppenheimer Adjusts Price Target on Immunocore Holdings to $86 From $85, Maintains Outperform Rating

MT Newswires

6 months ago

Sector Update: Health Care Stocks Gain Wednesday Afternoon

Compared to Estimates, Immunocore (IMCR) Q1 Earnings: A Look at Key Metrics

Zacks

6 months ago

Compared to Estimates, Immunocore (IMCR) Q1 Earnings: A Look at Key Metrics

MT Newswires

6 months ago

Immunocore Holdings' Q1 Swings to Net Income, Revenue Rises

Immunocore reports first quarter financial results and provides a business update

GlobeNewswire

6 months ago

Immunocore reports first quarter financial results and provides a business update

Wall Street Analysts Think Immunocore (IMCR) Could Surge 107.45%: Read This Before Placing a Bet

Zacks

6 months ago

Wall Street Analysts Think Immunocore (IMCR) Could Surge 107.45%: Read This Before Placing a Bet

MT Newswires

7 months ago

Mizuho Adjusts Price Target on Immunocore Holdings to $33 From $38, Keeps Neutral Rating

Immunocore to present at upcoming investor conferences

GlobeNewswire

7 months ago

Immunocore to present at upcoming investor conferences

Immunocore Holdings plc (IMCR): Among Stocks Receiving the Most Insider Love in March

Insider Monkey

7 months ago

Immunocore Holdings plc (IMCR): Among Stocks Receiving the Most Insider Love in March

Immunocore (IMCR) Moves 6.0% Higher: Will This Strength Last?

Zacks

7 months ago

Immunocore (IMCR) Moves 6.0% Higher: Will This Strength Last?

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025

GlobeNewswire

8 months ago

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025

Immunocore to present at upcoming investor conferences

GlobeNewswire

8 months ago

Immunocore to present at upcoming investor conferences

The Immunocore Holdings plc (NASDAQ:IMCR) Full-Year Results Are Out And Analysts Have Published New Forecasts

Simply Wall St.

8 months ago

The Immunocore Holdings plc (NASDAQ:IMCR) Full-Year Results Are Out And Analysts Have Published New Forecasts

Immunocore Holdings Full Year 2024 Earnings: Misses Expectations

Simply Wall St.

8 months ago

Immunocore Holdings Full Year 2024 Earnings: Misses Expectations

Immunocore Holdings PLC (IMCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com

8 months ago

Immunocore Holdings PLC (IMCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Immunocore Holdings PLC Earnings Call

MT Newswires

8 months ago

Immunocore Q4 Net Loss Widens, Revenue Rises

Immunocore reports fourth quarter and full year 2024 financial results and provides a business update

GlobeNewswire

8 months ago

Immunocore reports fourth quarter and full year 2024 financial results and provides a business update

Earnings To Watch: Immunocore Holdings PLC (IMCR) Reports Q4 2024 Result

GuruFocus.com

8 months ago

Earnings To Watch: Immunocore Holdings PLC (IMCR) Reports Q4 2024 Result

Lilly’s former M&A chief scours the landscape for potential deals as Immunocore’s new CFO

Pharma Voice

8 months ago

Lilly’s former M&A chief scours the landscape for potential deals as Immunocore’s new CFO

Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025

GlobeNewswire

8 months ago

Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025

Immunocore Gears Up to Report Q4 Earnings: Is a Beat in Store?

Zacks

8 months ago

Immunocore Gears Up to Report Q4 Earnings: Is a Beat in Store?

Wall Street Analysts Believe Immunocore (IMCR) Could Rally 113.13%: Here's is How to Trade

Zacks

9 months ago

Wall Street Analysts Believe Immunocore (IMCR) Could Rally 113.13%: Here's is How to Trade

Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

10 months ago

Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference

Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

10 months ago

Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference

MT Newswires

10 months ago

Immunocore Names Travis Coy Chief Financial Officer

Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development

GlobeNewswire

10 months ago

Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development

MT Newswires

10 months ago

Immunocore Doses First Patient in Phase 1 Trial of Potential Cancer Treatment

Immunocore announces first patient dosed in the Phase 1 trial of IMC-P115C, a half-life extended (HLE) ImmTAC candidate in patients with tumors that express PRAME

GlobeNewswire

10 months ago

Immunocore announces first patient dosed in the Phase 1 trial of IMC-P115C, a half-life extended (HLE) ImmTAC candidate in patients with tumors that express PRAME

Immunocore doses first subject in gastrointestinal cancer therapy trial

Clinical Trials Arena

10 months ago

Immunocore doses first subject in gastrointestinal cancer therapy trial

Immunocore announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancers

GlobeNewswire

10 months ago

Immunocore announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancers

Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?

Benzinga

10 months ago

Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?

MT Newswires

10 months ago

Morgan Stanley Downgrades Immunocore Holdings to Equalweight From Overweight, Cuts Price Target to $35 From $74

All You Need to Know About Immunocore (IMCR) Rating Upgrade to Strong Buy

Zacks

10 months ago

All You Need to Know About Immunocore (IMCR) Rating Upgrade to Strong Buy

Immunocore, EORTC announce enrollment of first patient in Phase 3 ATOM trial

TipRanks

10 months ago

Immunocore, EORTC announce enrollment of first patient in Phase 3 ATOM trial

MT Newswires

10 months ago

Immunocore Enrolls First Patient in Phase 3 Uveal Melanoma Trial

EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma

GlobeNewswire

10 months ago

EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma

MT Newswires

a year ago

Immunocore Says UK NICE Recommends Kimmtrak for Funding Through National Health Service in England

Immunocore announces reimbursement agreement in England for KIMMTRAK▼ for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma

GlobeNewswire

a year ago

Immunocore announces reimbursement agreement in England for KIMMTRAK▼ for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma

Does Immunocore (IMCR) Have the Potential to Rally 112.82% as Wall Street Analysts Expect?

Zacks

a year ago

Does Immunocore (IMCR) Have the Potential to Rally 112.82% as Wall Street Analysts Expect?

Immunocore Holdings plc (IMCR): This Small-Cap Stock Is Ready To Explode

Insider Monkey

a year ago

Immunocore Holdings plc (IMCR): This Small-Cap Stock Is Ready To Explode

Is Immunocore Holdings plc (IMCR) the Best Immunotherapy Stock to Buy Now?

Insider Monkey

a year ago

Is Immunocore Holdings plc (IMCR) the Best Immunotherapy Stock to Buy Now?

Wall Street Analysts Predict an 112.56% Upside in Immunocore (IMCR): Here's What You Should Know

Zacks

a year ago

Wall Street Analysts Predict an 112.56% Upside in Immunocore (IMCR): Here's What You Should Know

Immunocore to present at upcoming investor conferences

GlobeNewswire

a year ago

Immunocore to present at upcoming investor conferences

Immunocore reports third quarter financial results and provides a business update

GlobeNewswire

a year ago

Immunocore reports third quarter financial results and provides a business update

Immunocore (IMCR) Upgraded to Buy: Here's Why

Zacks

a year ago

Immunocore (IMCR) Upgraded to Buy: Here's Why

MT Newswires

a year ago

--UBS Initiates Immunocore Holdings With Sell Rating, $24 Price Target

Immunocore Holdings PLC (IMCR) Q2 2024 Earnings Call Highlights: Strong US Growth and Strategic ...

GuruFocus.com

a year ago

Immunocore Holdings PLC (IMCR) Q2 2024 Earnings Call Highlights: Strong US Growth and Strategic ...

Immunocore Holdings plc (IMCR): Worst 52-Week Low Stock to Buy Now

Insider Monkey

a year ago

Immunocore Holdings plc (IMCR): Worst 52-Week Low Stock to Buy Now

Immunocore Holdings plc (NASDAQ:IMCR) Ranks Low On The List Of Worst Falling Stocks To Buy

Insider Monkey

a year ago

Immunocore Holdings plc (NASDAQ:IMCR) Ranks Low On The List Of Worst Falling Stocks To Buy

Immunocore Holdings plc (IMCR) Hits 52-Week Low Despite 34% Surge in KIMMTRAK Sales

Insider Monkey

a year ago

Immunocore Holdings plc (IMCR) Hits 52-Week Low Despite 34% Surge in KIMMTRAK Sales

Immunocore Holdings plc (IMCR): Short Seller Sentiment is Bearish on This Cancer Stock

Insider Monkey

a year ago

Immunocore Holdings plc (IMCR): Short Seller Sentiment is Bearish on This Cancer Stock

Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer

GlobeNewswire

a year ago

Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer

Immunocore to present at the 2024 Cantor Global Healthcare Conference

GlobeNewswire

a year ago

Immunocore to present at the 2024 Cantor Global Healthcare Conference

Significant Portfolio Addition: T. Rowe Price Investment Management, Inc. ...

GuruFocus.com

a year ago

Significant Portfolio Addition: T. Rowe Price Investment Management, Inc. ...

Immunocore Holdings plc (IMCR): Top ADR Stock According to Hedge Funds

Insider Monkey

a year ago

Immunocore Holdings plc (IMCR): Top ADR Stock According to Hedge Funds

MT Newswires

a year ago

Immunocore Finance Chief Brian Di Donato to Resign

Immunocore announces transition of Chief Financial Officer

GlobeNewswire

a year ago

Immunocore announces transition of Chief Financial Officer

MT Newswires

a year ago

Mizuho Adjusts Immunocore Holdings' PT to $72 From $88, Keeps Outperform Rating

The Immunocore Holdings plc (NASDAQ:IMCR) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Simply Wall St.

a year ago

The Immunocore Holdings plc (NASDAQ:IMCR) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

MT Newswires

a year ago

Immunocore Shares Rise After Reporting Narrower Q2 Net Loss, Higher Revenue

Immunocore reports second quarter financial results and provides a business update

GlobeNewswire

a year ago

Immunocore reports second quarter financial results and provides a business update

Immunocore to report second quarter 2024 financial results and host call on August 8, 2024

GlobeNewswire

a year ago

Immunocore to report second quarter 2024 financial results and host call on August 8, 2024

Is There An Opportunity With Immunocore Holdings plc's (NASDAQ:IMCR) 32% Undervaluation?

Simply Wall St.

a year ago

Is There An Opportunity With Immunocore Holdings plc's (NASDAQ:IMCR) 32% Undervaluation?

MT Newswires

a year ago

Immunocore Randomizes First Patient in Phase 3 Trial of Cutaneous Melanoma Combination Treatment

Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma

GlobeNewswire

a year ago

Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

a year ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

a year ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

a year ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

a year ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

a year ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

a year ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

PR Newswire

a year ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

a year ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Dow Jones Falls On Jobs Report; GameStop Plunges Ahead Of 'Roaring Kitty' Live Event

Investor's Business Daily

a year ago

Dow Jones Falls On Jobs Report; GameStop Plunges Ahead Of 'Roaring Kitty' Live Event

Can DocuSign's AI offering accelerate growth?

Yahoo Finance Video

a year ago

Can DocuSign's AI offering accelerate growth?

Lab-on-a-Chip and Microfluidics World Congress 2024: 3-Day Conference (Laguna Hills, United States - November 18-20, 2024) Covering Technologies, Companies and Commercialization

GlobeNewswire

a year ago

Lab-on-a-Chip and Microfluidics World Congress 2024: 3-Day Conference (Laguna Hills, United States - November 18-20, 2024) Covering Technologies, Companies and Commercialization

Analysis-Mexico investors worry lopsided vote could threaten rule of law

Reuters

a year ago

Analysis-Mexico investors worry lopsided vote could threaten rule of law

AI Boom Giving Taiwan Semiconductor Sales A Boost

Investor's Business Daily

a year ago

AI Boom Giving Taiwan Semiconductor Sales A Boost

Taxes Served Corp. Acquires Blue Mountain Bookkeeping LLC to Enhance Tax and Bookkeeping Services

PR Newswire

a year ago

Taxes Served Corp. Acquires Blue Mountain Bookkeeping LLC to Enhance Tax and Bookkeeping Services

Smart Irrigation Market worth $3.0 billion by 2029 - Exclusive Report by MarketsandMarkets™

PR Newswire

a year ago

Smart Irrigation Market worth $3.0 billion by 2029 - Exclusive Report by MarketsandMarkets™

Business Wire

a year ago

Airstar Bank, with AMTD as a co-founder, successfully introduces Futu as A New Shareholder

Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response

GlobeNewswire

a year ago

Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response

Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024

GlobeNewswire

a year ago

Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024

Immunocore to present at the Jefferies Global Healthcare Conference

GlobeNewswire

a year ago

Immunocore to present at the Jefferies Global Healthcare Conference

MT Newswires

a year ago

Immunocore Converts Skin Cancer Therapy Phase 2/3 Trial to Phase 3

Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma

GlobeNewswire

a year ago

Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma

Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.

Barrons.com

a year ago

Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.

Analysts Have Made A Financial Statement On Immunocore Holdings plc's (NASDAQ:IMCR) First-Quarter Report

Simply Wall St.

a year ago

Analysts Have Made A Financial Statement On Immunocore Holdings plc's (NASDAQ:IMCR) First-Quarter Report

MT Newswires

a year ago

Immunocore Holdings' Shares Fall After Q1 Net Loss Widens

Immunocore Holdings PLC Reports Q1 2024 Earnings: Misses EPS Estimates, Surpasses Revenue Forecasts

GuruFocus.com

a year ago

Immunocore Holdings PLC Reports Q1 2024 Earnings: Misses EPS Estimates, Surpasses Revenue Forecasts

Immunocore reports first quarter financial results and provides a business update

GlobeNewswire

a year ago

Immunocore reports first quarter financial results and provides a business update

MT Newswires

a year ago

Leerink Partners Starts Immunocore Holdings With Outperform Rating, $74 Price Target

Share on Social Networks: